Anuh Pharma Limited (BOM:506260)
82.74
-2.69 (-3.15%)
At close: May 6, 2026
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 8.29 billion as of May 6, 2026. Its market cap has decreased by -4.95% in one year.
Market Cap
8.29B
Enterprise Value
8.16B
Revenue
7.68B
Ranking
n/a
PE Ratio
19.82
Stock Price
82.74
Market Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 8.29B, an increase of 3,678.84%. That is a compound annual growth rate of 21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 8.29B | 2.81% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 13.85B |
| Lincoln Pharmaceuticals | 13.66B |
| Syncom Formulations (India) | 13.22B |
| TTK Healthcare | 13.04B |
| Venus Remedies | 12.67B |
| Wanbury | 8.79B |
| Fermenta Biotech | 8.79B |
| Bharat Parenterals | 8.61B |